- |||||||||| esomeprazole / Generic mfg.
Trial completion, Enrollment change, Trial completion date: Gastric Functions & Proton Pump Inhibitor( PPI) Study (clinicaltrials.gov) - Feb 1, 2019 P4, N=155, Completed, Recruiting --> Completed | N=60 --> 155 | Trial completion date: Dec 2011 --> Feb 2016
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: Reference Values for Gastric Emptying (clinicaltrials.gov) - Jul 5, 2018
P=N/A, N=75, Completed, Recruiting --> Completed Recruiting --> Completed | Trial completion date: Aug 2016 --> May 2018 | Trial primary completion date: Aug 2016 --> May 2018
- |||||||||| Enrollment change, Trial withdrawal: Monosodium Glutamate on Gastric Emptying (clinicaltrials.gov) - Mar 22, 2018
P=N/A, N=0, Withdrawn, Recruiting --> Completed | Trial completion date: Aug 2016 --> May 2018 | Trial primary completion date: Aug 2016 --> May 2018 N=25 --> 0 | Not yet recruiting --> Withdrawn
- |||||||||| Trial primary completion date: Study of Promethazine for Treatment of Diabetic Gastroparesis (clinicaltrials.gov) - May 12, 2017
P2, N=24, Recruiting, Recruiting --> Completed | N=500 --> 37 | Trial primary completion date: Dec 2017 --> Feb 2015 Trial primary completion date: Dec 2015 --> Dec 2020
- |||||||||| Trial primary completion date: Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis (clinicaltrials.gov) - Feb 2, 2017
P2, N=50, Recruiting, Recruiting --> Terminated | Trial primary completion date: Dec 2014 --> Sep 2016; last patient recruited Feb 2015,completion of data review; study data do not meet statistical significance to answer proposed study question Trial primary completion date: Dec 2016 --> Dec 2017
- |||||||||| Trial termination, Trial primary completion date: Domperidone in Refractory Gastroparesis (clinicaltrials.gov) - Jun 23, 2016
P2, N=30, Terminated, Active, not recruiting --> Terminated | Trial primary completion date: Aug 2016 --> Dec 2016; sponsor internal decision Suspended --> Terminated | Trial primary completion date: Dec 2011 --> Jul 2011; Enrolled subjects were unable to receive drug from dispensing pharmacy.
- |||||||||| Trial completion, HEOR: Medico-economic Evaluation of ENTERRA Therapy (clinicaltrials.gov) - May 27, 2016
P=N/A, N=220, Completed, Suspended --> Terminated | Trial primary completion date: Dec 2011 --> Jul 2011; Enrolled subjects were unable to receive drug from dispensing pharmacy. Active, not recruiting --> Completed
- |||||||||| Enrollment change, Trial primary completion date: Enterra Therapy Gastric Stimulation System (clinicaltrials.gov) - Apr 20, 2016
P4, N=4, Terminated, Trial primary completion date: Nov 2015 --> Nov 2016 N=25 --> 4 | Trial primary completion date: Dec 2015 --> Sep 2008
- |||||||||| erythromycin / Generic mfg.
Trial completion: Erythromycin in Parkinson's Disease (clinicaltrials.gov) - Dec 14, 2015 P=N/A, N=15, Completed, Trial primary completion date: Dec 2015 --> May 2017 Recruiting --> Completed
|